Feature Channels: Blood

Filters close
Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Released: 30-Jan-2024 9:45 AM EST
JMIR Perioperative Medicine Invites Submissions on Perioperative Blood Management
JMIR Publications

JMIR Publications is pleased to announce a new theme issue titled “Perioperative Blood Management” in JMIR Perioperative Medicine.

   
Newswise: RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia
Released: 29-Jan-2024 12:05 PM EST
RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia
Elsevier

Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the diagnosis and treatment of this heterogeneous leukemia, reports The Journal of Molecular Diagnostics.

Released: 29-Jan-2024 10:05 AM EST
Is lung cancer treatment working? This chip can tell from a blood draw
University of Michigan

Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient's blood to determine how well a treatment is working by the fourth week, according to a new University of Michigan study.

Newswise: Hydroxyurea significantly reduces infections in children with sickle cell anemia
Released: 29-Jan-2024 9:05 AM EST
Hydroxyurea significantly reduces infections in children with sickle cell anemia
Indiana University

IU School of Medicine investigators and their collaborators in Uganda has revealed that hydroxyurea significantly reduces infections in children with sickle cell anemia, which enhances strong evidence of hydroxyurea’s effectiveness and could ultimately reduce death in children in Africa.

24-Jan-2024 8:00 AM EST
Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer
The Society of Thoracic Surgeons

In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part of the clot breaking off and lodging in the lung, resulting in a pulmonary embolism (PE).

Newswise: MU study shows blood pressure drug can reduce anxiety for people with autism
Released: 23-Jan-2024 5:05 PM EST
MU study shows blood pressure drug can reduce anxiety for people with autism
University of Missouri, Columbia

A new study at the University of Missouri’s Thompson Center for Autism and Neurodevelopment found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with autism spectrum disorder (ASD).

Released: 22-Jan-2024 1:05 PM EST
Scientists Identify Mutations That Cause Inherited Kidney Disease
Wake Forest University School of Medicine

Researchers at Wake Forest University School of Medicine and the First Faculty of Medicine of Charles University in Prague, Czech Republic, have discovered a new genetic cause of inherited kidney disease.

Newswise: Experts Recommend Caution on the Use of Non-Sugar Sweeteners
Released: 22-Jan-2024 11:10 AM EST
Experts Recommend Caution on the Use of Non-Sugar Sweeteners
George Washington University

Despite ongoing concerns about the health impacts of non-sugar sweeteners such as aspartame, sucralose and stevia, these sweeteners are increasingly found in a variety of foods and beverages, including those aimed at children.

Newswise: Cedars-Sinai Develops New Tools to Improve Pancreatic Cancer Patient Care
Released: 22-Jan-2024 11:05 AM EST
Cedars-Sinai Develops New Tools to Improve Pancreatic Cancer Patient Care
Cedars-Sinai

Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic cancer survival.

Released: 22-Jan-2024 4:00 AM EST
Uncovering Language Disparity of ChatGPT on Retinal Vascular Disease Classification: Cross-Sectional Study
Journal of Medical Internet Research

Background: Benefiting from rich knowledge and the exceptional ability to understand text, large language models like ChatGPT have shown great potential in English clinical environments. However, the performance of ChatGPT in non-Eng...

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Released: 19-Jan-2024 9:05 AM EST
Wren Laboratories Dr. Mark Kidd to speak at 2024 Precision Medicine World Conference
Wren Laboratories

The presentation will focus on the use of mRNA in Liquid Biopsies as a platform for precision diagnostics

Released: 19-Jan-2024 7:05 AM EST
Researchers improve blood tests’ ability to detect and monitor cancer
Massachusetts Institute of Technology (MIT)

Tumors constantly shed DNA from dying cells, which briefly circulates in the patient’s bloodstream before it is quickly broken down.

Newswise: UTHealth Houston opens recruitment in RISE-UP clinical drug trial for people with sickle cell anemia
Released: 18-Jan-2024 6:05 PM EST
UTHealth Houston opens recruitment in RISE-UP clinical drug trial for people with sickle cell anemia
University of Texas Health Science Center at Houston

A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth Houston.

Newswise: Researcher, Through Spinoff, Develops a Handheld White Blood Cell Tracker
Released: 18-Jan-2024 4:05 PM EST
Researcher, Through Spinoff, Develops a Handheld White Blood Cell Tracker
Rutgers University-New Brunswick

A Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person’s white blood cells with a single drop of blood, similar to the way glucometers rapidly scan for blood sugar levels. T

17-Jan-2024 5:00 AM EST
CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.

Newswise: The Medical Minute: Calling all blood donors – especially young ones
Released: 17-Jan-2024 2:05 PM EST
The Medical Minute: Calling all blood donors – especially young ones
Penn State Health

Blood banks are looking for donors everywhere, but if you’re 17 to 35, step to the front of the line. A Penn State Health expert discusses why younger donors are needed more than ever.

Released: 17-Jan-2024 10:05 AM EST
Researchers Identify Key Characteristics Associated with Improved CAR T Outcomes in Large B Cell Lymphoma
Moffitt Cancer Center

Axi-cel CAR T targets the CD19 molecule on large B-cell lymphoma cells. The ZUMA-7 trial demonstrated that axi-cel reduced the risk of disease progression, the need for new therapy, or death by 60% compared to standard therapy. Despite these positive outcomes in event-free survival and overall survival, some patients did not respond well to therapy or relapsed quickly after treatment. Researchers wanted to assess if there were specific tumor characteristics associated with improved outcomes that could better inform treatment selection. Their findings were published today in Nature Medicine.

Newswise: RUDN doctors: for personalized treatment of inflammation, individual sensitivity to hypoxia must be considered
Released: 16-Jan-2024 5:05 AM EST
RUDN doctors: for personalized treatment of inflammation, individual sensitivity to hypoxia must be considered
Scientific Project Lomonosov

RUDN University doctors discovered that the body’s response to inflammation depends on individual sensitivity or resistance to oxygen deficiency.

Newswise: HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia
Released: 12-Jan-2024 2:05 PM EST
HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia
St. Jude Children's Research Hospital

Using CRISPR/Cas9, scientists at St. Jude Children’s Research Hospital identified RBM5 as a vital component of leukemia cell fitness, making it a promising target for drug development.

Newswise: UTEP Researchers Discover Compound that Fights Leukemia, Lymphoma
Released: 11-Jan-2024 7:05 PM EST
UTEP Researchers Discover Compound that Fights Leukemia, Lymphoma
University of Texas at El Paso

Renato Aguilera, Ph.D., a professor in the Department of Biological Sciences at The University of Texas at El Paso, is the principal investigator on the project that identified the promising compound, called thiophene F-8.

Newswise: Updated genomic landscape for pediatric acute myeloid leukemia enables new treatment possibilities
Released: 11-Jan-2024 11:05 AM EST
Updated genomic landscape for pediatric acute myeloid leukemia enables new treatment possibilities
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital refined and enhanced the classification system for a type of pediatric leukemia using genomic and transcriptomic analysis.

Released: 11-Jan-2024 10:05 AM EST
Reduced blood lead levels linked to lower blood pressure
Columbia University, Mailman School of Public Health

Ten-year reductions in blood lead levels correlated with cardiovascular health improvements in American Indian adults.

Released: 11-Jan-2024 8:05 AM EST
Higher viral load during HIV infection can shape viral evolution
Oxford University Press

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.

9-Jan-2024 5:05 PM EST
Reduced blood lead levels linked to lower blood pressure in American Indians
National Institute of Environmental Health Sciences (NIEHS)

Researchers have linked a decade-long decline in the blood lead levels of American Indian adults to long-term cardiovascular health benefits, including reduced blood pressure levels and a reduction in a marker associated with hypertrophic cardiomyopathy and heart failure.

Newswise: Developing Diagnostics for a Deadly Elephant Disease
Released: 10-Jan-2024 3:05 PM EST
Developing Diagnostics for a Deadly Elephant Disease
Tufts University

Elephant endotheliotropic herpesvirus is the leading cause of death for Asian elephant calves and is a danger to young African elephants as well.

Newswise: Blood test distinguishes neuroendocrine subtype of advanced prostate cancer
9-Jan-2024 2:05 PM EST
Blood test distinguishes neuroendocrine subtype of advanced prostate cancer
Dana-Farber Cancer Institute

Researchers at Dana-Farber Cancer Institute and the University of Trento, Italy, have developed a blood test, described in Cancer Discovery, that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma.

Newswise:Video Embedded exposure-to-high-humidity-and-temperature-in-pregnancy-could-influence-blood-pressure-changes-in-childhood
VIDEO
Released: 10-Jan-2024 8:05 AM EST
Exposure to high humidity and temperature in pregnancy could influence blood pressure changes in childhood
University of Bristol

Outdoor humidity and temperature levels during pregnancy could affect the future blood pressure of the unborn child, according to new research by the University of Bristol, published in JACC: Advances.

Newswise: A Game Changer for Blood Cancer Treatment in New Mexico
Released: 8-Jan-2024 4:05 PM EST
A Game Changer for Blood Cancer Treatment in New Mexico
University of New Mexico Comprehensive Cancer Center

For the first time ever in New Mexico, doctors at UNM Comprehensive Cancer Center have treated blood cancer patients by transplanting cells from a donor. Late last year, Matthew Fero, MD, FACP, and the Stem Cell and Bone Marrow Transplant team completed the first procedure, known as an allogeneic stem cell transplant.

Newswise: Blood flow changes in the eyes could influence visual symptoms of migraines
Released: 5-Jan-2024 3:05 PM EST
Blood flow changes in the eyes could influence visual symptoms of migraines
University of California, Los Angeles (UCLA), Health Sciences

Differences in blood flow in the retina could explain why some migraine patients experience visual symptoms while others do not, according to UCLA study.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: Minimizing Immunotherapy’s Potentially Harmful Side Effects
2-Jan-2024 1:05 PM EST
Minimizing Immunotherapy’s Potentially Harmful Side Effects
Sylvester Comprehensive Cancer Center

New research from Sylvester Comprehensive Cancer Center indicates that providing prophylactic treatment before immunotherapy can significantly reduce the rate of cytokine release syndrome (CRS) in multiple myeloma patients. Study appears Jan. 4, 2024, in Blood Cancer Discovery.

Released: 4-Jan-2024 8:50 AM EST
Little (a), Big Risk: G3 Therapeutics Sets Out to Unravel Lp(a)-Driven Cardiovascular Disease (Lipoprotein(a)-Driven Cardiovascular Disease)
G3 Therapeutics

G3 Therapeutics ("G3"), a global leader in the use of multiomic biological Big Data, has initiated a groundbreaking initiative to unravel the contribution of Lipoprotein(a) ["Lp(a)"] to cardiovascular disease (CVD).

Newswise: An enhanced brain delivery of antibodies heightens the potential to treat brain diseases
Released: 4-Jan-2024 5:05 AM EST
An enhanced brain delivery of antibodies heightens the potential to treat brain diseases
University of Alabama at Birmingham

The blood-brain barrier blocks the entry of antibodies into the brain. This limits the potential use of antibody therapeutics to treat brain diseases, such as brain tumors.

Released: 3-Jan-2024 5:05 PM EST
Risk model based on routine blood work predicts treatment response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
University of Eastern Finland

A risk model developed by researchers can help to identify cancer patients who could benefit from immune checkpoint inhibitors, ICIs. Published in BMC Cancer, the study was conducted at the University of Eastern Finland and Kuopio University Hospital.

Newswise: Virginia Tech researchers awarded nearly $2 million to explore new treatment for Type 2 diabetes and obesity
Released: 3-Jan-2024 9:30 AM EST
Virginia Tech researchers awarded nearly $2 million to explore new treatment for Type 2 diabetes and obesity
Virginia Tech

A team of Virginia Tech researchers was awarded nearly $2 million from the National Institute of Diabetes and Digestive and Kidney Disease, part of the National Institutes of Health, to explore novel approaches for treating Type 2 diabetes and obesity. Type 2 diabetes affects more than 38.4 million Americans, with an estimated 1.

Newswise: Hypertensive Disorders in Pregnancy Associated With Lasting Effects on the Heart
Released: 22-Dec-2023 9:30 AM EST
Hypertensive Disorders in Pregnancy Associated With Lasting Effects on the Heart
Cedars-Sinai

New research from the Smidt Heart Institute at Cedars-Sinai found that women who developed signs of elevated blood pressure during pregnancy were more likely to have residual evidence of abnormal heart structure and function up to a decade after the pregnancy.

Released: 20-Dec-2023 3:05 PM EST
Working with Big Data requires a lot of power! The latest research and features on Supercomputing
Newswise

With the rise in machine learning applications and artificial intelligence, it's no wonder that more and more scientists and researchers are turning to supercomputers. Supercomputers are commonly used for making predictions with advanced modeling and simulations. This can be applied to climate research, weather forecasting, genomic sequencing, space exploration, aviation engineering and more.

       
Released: 20-Dec-2023 3:05 PM EST
December Tip Sheet from Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center

How interactions between tumor genes, microenvironment affect multiple myeloma treatment responses, a new AI technique could guide glioblastoma treatment, new research shows birth country a key risk factor in stomach cancer, how petrochemicals fuel cancer risk and more are included in this month’s tip sheet.

Released: 19-Dec-2023 1:05 PM EST
Where to place bleeding control first aid equipment to maximize lives saved
Linkoping University

In the event of an accident or an attack, members of the public can save lives by performing first aid measures until the arrival of emergency medical services. But it is not enough that people see themselves as life-saving immediate responders, prepared and able to act.

Newswise: Iowa State researchers discover crucial step in creating blood stem cells
Released: 19-Dec-2023 12:05 PM EST
Iowa State researchers discover crucial step in creating blood stem cells
Iowa State University

A microbial sensor that helps identify and fight bacterial infections also plays a key role in the embryonic development of blood stem cells, valuable new insight in the effort to create patient-derived blood stem cells that could eliminate the need for bone marrow transplants.

Newswise: NCCN Announces Funding for Research on Multiple Myeloma Treatment
Released: 19-Dec-2023 9:00 AM EST
NCCN Announces Funding for Research on Multiple Myeloma Treatment
National Comprehensive Cancer Network® (NCCN®)

The National Comprehensive Cancer Network’s Oncology Research Program selects projects to evaluate the effectiveness of elranatamab in the treatment of multiple myeloma.

Released: 18-Dec-2023 5:05 PM EST
Loyola Medicine Is Nationally Recognized for Efforts to Improve Blood Pressure Control
Loyola Medicine

The American Heart Association® and the American Medical Association recognized 15 Loyola Medicine primary care practices for their commitment to improving blood pressure control rates by awarding them Gold+ level recognition as part of Target: BP™.



close
2.57955